About
About Sunflower Pharmaceutical Group Co.,Ltd
Sunflower Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of Chinese medicines in China and internationally. It offers traditional Chinese medicines, chemical drugs, biological drugs, and health and wellness products, as well as adult and children's medicines for various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold ailments, rheumatism and bone disease, cardiovascular and cerebrovascular diseases, and general health. The company is also involved in leasing and business services; scientific research and technical services; and wholesale and retail trade. It sells its products under the Sunflower and Little Sunflower brand names. The company was founded in 2005 and is headquartered in Harbin, China.
Visit company website
5 years, 5 months ago
Sunflower Pharmaceutical Group Co.,Ltd is currently in a long term uptrend where the price is trading 10.3% above its 200 day moving average.
From a valuation standpoint, the stock is 76.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.
Sunflower Pharmaceutical Group Co.,Ltd's total revenue sank by 20.7% to $606M since the same quarter in the previous year.
Its net income has increased by 17.5% to $80M since the same quarter in the previous year.
Finally, its free cash flow grew by 214.4% to $100M since the same quarter in the previous year.
Based on the above factors, Sunflower Pharmaceutical Group Co.,Ltd gets an overall score of 4/5.